[ad_1]
Addis Ababa – Ethiopia has joined the COVID-19 medical research initiative led by the World Health Organization (WHO), according to the Armauer Hansen Research Institute (AHRI).
In his press conference today on ongoing research work, the Institute’s Deputy Director General, Dr. Alemseged Abdissa, said that the institute is working on drug testing in collaboration with WHO.
The drug test will work in conjunction with 30 countries around the world, he said, adding that Ethiopia after Egypt and South Africa have joined the Africa research network.
The trial involved more than 12,000 participants and 500 hospitals, making it a large research network developed since the COVID-19 outbreak.
He also said that the drug test will be used to determine if other drugs can be used to treat coronavirus.
According to Alemseged, the experiment was not only leaking drugs, but also a testament to the potential of drug testing. The cost of the research will be borne by the Ministry of Health.